Anyone read it? I apparently can’t post a link or mention it even obliquely because of my peon status in this community, but the company is less than two years old and pulls in 3 million USD per day. Ran by one guy and his brother.
NYT article about a telehealth provider
- Thread starter onewalker
- Start date
FarmgirlRebel
GLP-1 Enthusiast
Here ya go...article w/o the NYT paywall
www.drugdiscoverytrends.com
The New York Times spotlighted MEDVi. The FDA had already warned the self-proclaimed 'fastest growing company in history.' - Drug Discovery and Development
Drug Discovery and Development covers strategies and technologies related to pharmaceutical research and development and drug formulation.
www.drugdiscoverytrends.com
DunningKruger
GLP-1 Enthusiast
What stood out to you about it? The AI doctor/ad fraud, or the part where they appear to be making a fortune as the consumer-facing middleman, bringing in the patient, routing them to prescribers, and arranging access to medication they don’t actually make or sell themselves?
Also, if they're using false doctors in their marketing, it makes one wonder if their 24/7 support doctors are real or a well-crafted AI agent.
Also, if they're using false doctors in their marketing, it makes one wonder if their 24/7 support doctors are real or a well-crafted AI agent.
Good-Heart6425
GLP-1 Enthusiast
Thank you for your pay-wall-absent link to this excellent article. The story was consistent with my own personal experiences with the company described. Influenced by their Facebook advertisement, Medvi was the telehealth company that I paid $499/month for my initial 4 months of compounded Tirzepatide before I switched to DIY compounding. I’m a healthcare provider. It became obvious that the CareValidate Telehealth platform’s employees I spoke with had no medical training or licensing. They were unfamiliar with GLP-2 tutorial content readily available online elsewhere. The usual email responses I got to my questions were just cut and paste echoing of whatever I had written, likely AI generated. One of the D.O. doctors described in the article wrote my telehealth prescriptions each month after our monthly phone consult appointments. Hoping to get maximum value for my dollars, I minimized description of my side effects so that my dosage escalation would proceed at the maximum dosage schedule. I’m grateful that my health survived, that I found a grey market reseller of lypholized vials and that eventually I found myself here. Big thanks-a-millions to our Gonkulator, Moderators, and Specialists and to the contributors who have so generously shared their opinions and experiences.Here ya go...article w/o the NYT paywall
The New York Times spotlighted MEDVi. The FDA had already warned the self-proclaimed 'fastest growing company in history.' - Drug Discovery and Development
Drug Discovery and Development covers strategies and technologies related to pharmaceutical research and development and drug formulation.
Last edited:
Good-Heart6425
GLP-1 Enthusiast
I just checked MedVi’s website today. Their fraudulent weight loss page still has a photo of a round tablet marked NOVO next to a square bottle marked “WEGOVY [semaglutide] Rx only.” MedVi’s blatant disregard for Novo Nordisk‘s intellectual property suggests that perhaps FDA is only interested in protecting domestic pharmaceutical corporations.
